Can big pharma survive new biology?
April 14 2008
Seminar Room 1.06,
ESRC Innogen Centre,
Old Surgeons' Hall,
High School Yards,
Organised by: Innogen
All welcome, no need to book
The big pharmaceutical firms seem to be surviving new biology. There have been, as yet, no society shattering technology changes to match the PC, the mobile or the internet. The long term sectoral dominance of multinational pharma companies has been remarkable. During a fifty year period when the
auto- and electrical industries have been dramatically transformed, the drug pipeline system has endured. But can this last?
Dave will focus on some of the changes, using results from colleagues in Innogen. He will look at changes both within the core pharma industry but also the growth of Indian pharmaceuticals and the prospects for high-tech start-ups.